Latinib

Latinib uses and dosage

Latinib (Lapatinib), generic Tykerb is a prescription medicine used to treat human epidermal growth factor receptor type 2 (HER2) positive advanced or metastatic breast cancer that has spread to other parts of the body and who have already been treated with other chemotherapy medications including anthracycline, taxane, and trastuzumab (Herceptin). Latinib manufactured by Drug International Ltd. in Bangladesh. Lapatinib has to take orally once daily on an empty stomach at least 1 hour before or 1 hours after a meal.

Latinib side effects

The most common adverse reactions of Lapatinib are: Nausea, vomiting, upset stomach, mouth sores, mild rash, dry skin, and trouble sleeping.

Originator brand

Tykerb by GlaxoSmithKline (GSK)

Made by

Drug International Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.